Extended lymphadenectomy in gastric cancer is crucial

World Journal of Surgery

Volumn 37, Issue 8, 2013, Pages 1768-1772

  Ferri, Lorenzo ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH NEOPLASMS; ARTICLE; METHODOLOGY; STOMACH TUMOR;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS;

EID: 84880799617     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2069-7     Document Type: Article

References (25)

1. Wanebo HJ, Blackinton D, Kouttab N, et al. (1993) Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. Am J Surg 166:389-394
2. Sasako M, Sano T, Yamamoto S, et al. (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359:453-462
3. Bang YJ, Kim YW, Yang HK, et al. (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379:315-321
4. Macdonald JS, Smalley SR, Benedetti J, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730
5. Cunningham D, Allum WH, Stenning SP, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
6. Sakuramoto S, Sasako M, Yamaguchi T, et al. (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810-1820
7. Kajitani T (1981) The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 11:127-139
8. Folli S, Morgagni P, Roviello F, et al. (2001) Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol 31:495-499
9. Siewert JR, Bottcher K, Stein HJ, et al. (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449-461
10. Choi WH, Kim S, Shen J, et al. (2007) Prognostic significance of perinodal extension in gastric cancer. J Surg Oncol 95:540-545
11. Smith DD, Schwarz RR, Schwarz RE (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23:7114-7124
12. Roviello F, Rossi S, Marrelli D, et al. (2006) Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 94:275-280 discussion 274
13. National Cancer Database 2004
14. Wu CW, Hsiung CA, Lo SS, et al. (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309-315
15. Degiuli M, Sasako M, Ponti A, et al. (1998) Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 16:1490-1493
16. Bonenkamp JJ, Hermans J, Sasako M, et al. (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908-914
17. Macdonald JS, Smalley S, Benedetti J, et al. (2004) Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update of the results of Intergroup Study INT-0116 (SWOG 9008). Gastrointestinal Cancers Symposium. J Clin Oncol 27:205s
18. Cuschieri A, Weeden S, Fielding J, et al. (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522-1530
19. Birkmeyer JD, Siewers AE, Finlayson EV, et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137
20. Edwards P, Blackshaw GR, Lewis WG, et al. (2004) Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 90:1888-1892
21. Lee JH, Ryu KW, Park SR, et al. (2006) Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol 13:1175-1181
22. Degiuli M, Sasako M, Ponti A, et al. (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90:1727-1732
23. Degiuli M, Sasako M, Ponti A, et al. (2010) Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg 97:643-649
24. Songun I, Putter H, Kranenbarg EM, et al. (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:439-449
25. Hartgrink HH, van de Velde CJ, Putter H, et al. (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069-2077